---
title: "Endologix announces 36-month results of DETOUR2 study"
date: "2024-11-06T11:57:37.000Z"
publishedDate: "6 novembre 2024"
summary: "Endologix has announced the final 36-month results from the DETOUR2 study—a prospective, single-arm, international, multicentre clinical evaluation of the novel Detour system for fully percutaneous femoropopliteal bypass procedures. A press release details that the findings highlight the durable efficacy of the Detour system, which is comparable to open bypass with a synthetic graft."
importance: ""
sourceUrl: "https://vascularnews.com/endologix-announces-36-month-results-of-detour2-study/"
tags: ["France", "Actualité", "Vascular News — Latest"]
permalink: "/papers/2024-11-06-endologix-announces-36-month-results-of-detour2-study"
imageUrl: "https://vascularnews.com/wp-content/uploads/sites/7/2024/11/Sean-Lyden-at-VIVA-2024-936x1024.png"
imageCredit: "Image de l’article — droits possiblement réservés — https://vascularnews.com/endologix-announces-36-month-results-of-detour2-study/"
---

![Endologix announces 36-month results of DETOUR2 study](https://vascularnews.com/wp-content/uploads/sites/7/2024/11/Sean-Lyden-at-VIVA-2024-936x1024.png)

*Crédit image : Image de l’article — droits possiblement réservés — https://vascularnews.com/endologix-announces-36-month-results-of-detour2-study/*

## L’essentiel

Endologix has announced the final 36-month results from the DETOUR2 study—a prospective, single-arm, international, multicentre clinical evaluation of the novel Detour system for fully percutaneous femoropopliteal bypass procedures. A press release details that the findings highlight the durable efficacy of the Detour system, which is comparable to open bypass with a synthetic graft.

## Lien source

https://vascularnews.com/endologix-announces-36-month-results-of-detour2-study/
